by Children’s Hospital Boston Capping decades of research, a new study may offer a breakthrough in treating dyskeratosis congenita and other so-called telomere diseases, in which cells age prematurely. Using cells donated by patients with the disease, researchers at the Dana-Farber/Boston Children’s Cancer and Blood Disorders Center identified several small molecules that appear to reverse...
by Brian Burns, Massachusetts General Hospital Medical images for a wide range of diseases, including coronavirus 19 (COVID-19), can now be more easily viewed, compared, and analyzed using a breakthrough web-based imaging platform developed by Massachusetts General Hospital (MGH) and collaborating researchers. The Open Health Imaging Foundation (OHIF) web viewer was originally developed with grant...
Exotic molecule linked to ozone also at work in chronic diseases and cancers, and even the decomposition of food. Scientists at the U.S. Department of Energy’s Lawrence Berkeley National Laboratory (Berkeley Lab) have made a surprising discovery that could help explain our risk for developing chronic diseases or cancers as we get older, and how...
by Michael Tullier, Tuskegee University Immune therapy research by a team of Tuskegee University faculty scientists and doctoral students—in partnership with the National Institutes of Health—shows great promise in the ability to reprogram immune cells, kill cancer cells and halt tumor growth in several types of cancer. These research findings are described in detail in...
